▼ -54.57% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for CLS Holdings USA in the last 3 months. The average price target is $0.10, with a high forecast of $0.10 and a low forecast of $0.10. The average price target represents a -54.57% upside from the last price of $0.22.
The current consensus among 2 contributing investment analysts is to buy stock in CLS Holdings USA. This rating has held steady since August 2020, when it changed from a Hold consensus rating.
CLS Holdings USA, Inc. focuses on the extraction and conversion of cannabinoids in the United States. The company extracts various cannabinoids from the cannabis plants and converts into concentrates, such as oils, waxes, edibles, and shatters. Its concentrates are used for electronic cigarettes vaporization, and pharmaceutical and other purposes. The company also offers consulting services to cannabis-related businesses comprising growers, dispensaries, and laboratories. CLS Holdings USA, Inc. was founded in 2014 and is based in Las Miami, Florida.